Higher Steaks rebrands as 'Uncommon', raises $30m in Series A

Uncommon, our Land x Launch™ Global Incubator Programme – Gateway to Asia (in partnership with Innovate UK) cohort 2 alumnus, has raised $30million in their latest Series A round.

This round was led by Balderton Capital and Lowercarbon Capital, with participation from Red Alpine, East Alpha, Max and Sam Altman, Miray Zaki, and Sebastiano Castiglioni.

Funds from this round will bring Uncommon closer to the markets through scaling up production at the firm’s headquarters at Cambridge Technopark. Furthermore, Uncommon will also be kickstarting the regulatory approvals process.

Using RNA technology to disrupt the cultivated meat sector

With their unique RNA technology, Uncommon is one step closer than its peers to hitting the markets. Simultaneously, Uncommon will be catalysing the cultivated meat industry by speeding up the cell differentiation process and lowering media costs, without the need for gene editing.

Addressing the investment climate and Uncommon’s outstanding achievement, co-founder Benjamina Bollag shares her belief that “…what really made investors invest in us is how differentiated our technology is”.

Michael Sidler, partner at Red Alpine echoes her sentiment, “Uncommon’s completely novel approach holds immense potential to revolutionize the cultivated meat industry and overcome the notorious scalability and pricing obstacles that companies in this field face”.

Congratulations to the team at Uncommon!